ClinicalTrials.Veeva

Menu

Vascular Function, Fish Protein Hydrolysates and Type 2 Diabetes Mellitus

U

Universidade Federal do Rio de Janeiro

Status

Completed

Conditions

Diabetes Mellitus, Type 2

Treatments

Other: Fish protein hydrolysates
Other: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT03318913
53392216.0.0000.5699

Details and patient eligibility

About

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease of abnormal carbohydrate metabolism which is related with high morbidity and mortality rates caused by its complications. One of the major diabetes-related arterial phenotypes thought to be responsible for development of cardiovascular disease is endothelial dysfunction. Nitric oxide (NO) is a potent molecule derived of endothelium, which plays key role in control of vascular tone. In T2DM present endothelial dysfunction due to reduced NO bioavailability. Fish protein hydrolysates (FPH) have been showed to present antioxidant peptides (and high value of ACE inhibition activity. Therefore, the present study aimed to examine whether single dose of FPH ingestion would reversal macro- and microvascular endothelial dysfunction in T2DM.

Enrollment

22 patients

Sex

All

Ages

18 to 90 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Type 2 diabetes mellitus

Exclusion criteria

  • History of symptomatic coronary artery disease;
  • Stroke or other known atherosclerotic disease;
  • Cancer;
  • HIV positive;
  • Alcohol or drug abuse within the past 6 months previous the visit 1;
  • use any antioxidant supplementation

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

22 participants in 3 patient groups, including a placebo group

Health control
No Intervention group
Description:
Health young subjects free of diabetes mellitus and nutritional intervention
DM Placebo
Placebo Comparator group
Description:
Sucralose
Treatment:
Other: Placebo
DM FHP
Active Comparator group
Description:
Fish protein hydrolysates
Treatment:
Other: Fish protein hydrolysates

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems